19 June 2013
Keywords: sepracor, submits, nda, levalbuterol, submitted, new, drug
Article | 09 July 1997
Sepracor has submitted a New Drug Application to the US Food and DrugAdministration for approval to market levalbuterol HCl inhalation
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 July 1997
4 September 1997
© 2013 thepharmaletter.com